IMMUNIQUE – MEDIPOST

COMPANY
R&D
PRODUCTS
BUSINESS
IR
PR
- MEDIPOST on Media
- Corporate Brochure
CONTACT US

MEDIPOST starts cord blood-derived immune cell therapy development with the establishment of its subsidiary “IMMUNIQUE”

2021/04/02

Latest News

MEDIPOST Recruits Local Experts to U.S. Subsidiary, Accelera…

2024/12/06

MEDIPOST Completes Administration for Phase 3 Clinical Trial…

2024/11/22

MEDIPOST Affiliate OmniaBio Hosts Opening Ceremony for New C…

2024/10/21

MEDIPOST Discusses CARTISTEM® Partnerships and Licensing Opp…

2024/10/14

MEDIPOST’s CARTISTEM® Reaches Milestone of treating 30,000 P…

2024/06/24

Contacts

21, Daewangpangyo-ro 644, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea MEDIPOST Co., Ltd.
TEL : 82-2-3465-6677

Latest News

MEDIPOST Recruits Local Experts to U.S.…2024.12.06

MEDIPOST Completes Administration for Ph…2024.11.22

MEDIPOST Affiliate OmniaBio Hosts Openin…2024.10.21

MEDIPOST Discusses CARTISTEM® Partnershi…2024.10.14

MEDIPOST’s CARTISTEM® Reaches Milestone…2024.06.24

Family Site

· CELLTREE Cord Blood Bank
· MOVITA Nutritional Supplements

· LOCATION
· PRIVACY POLICY

©Copyright – The Future of Biotechnology, MEDIPOST